135 related articles for article (PubMed ID: 36821377)
1. Regarding Kaya P et al. "Predictive Factors for the Prognosis of Vogt-Koyanagi-Harada Disease".
Ruiz-Lozano RE; Rodriguez-Garcia A
Ocul Immunol Inflamm; 2023 Oct; 31(8):1736-1737. PubMed ID: 36821377
[TBL] [Abstract][Full Text] [Related]
2. Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: differentiation between choroidal scars and active lesions.
Knecht PB; Mantovani A; Herbort CP
Int Ophthalmol; 2013 Oct; 33(5):571-7. PubMed ID: 23277207
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
Herbort CP; Mantovani A; Bouchenaki N
Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
[TBL] [Abstract][Full Text] [Related]
4. Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review.
Herbort CP; Tugal-Tutkun I; Abu-El-Asrar A; Gupta A; Takeuchi M; Fardeau C; Hedayatfar A; Urzua C; Papasavvas I
Eye (Lond); 2022 Jan; 36(1):29-43. PubMed ID: 34145419
[TBL] [Abstract][Full Text] [Related]
5. Need for Quantitative Measurement Methods for Posterior Uveitis: Comparison of Dual FA/ICGA Angiography, EDI-OCT Choroidal Thickness and SUN Vitreous Haze Evaluation in Stromal Choroiditis.
Fabro F; Herbort CP
Klin Monbl Augenheilkd; 2018 Apr; 235(4):424-435. PubMed ID: 29669371
[TBL] [Abstract][Full Text] [Related]
6. Enhanced depth imaging is less suited than indocyanine green angiography for close monitoring of primary stromal choroiditis: a pilot report.
Balci O; Gasc A; Jeannin B; Herbort CP
Int Ophthalmol; 2017 Jun; 37(3):737-748. PubMed ID: 27486023
[TBL] [Abstract][Full Text] [Related]
7. Contribution of dual fluorescein and indocyanine green angiography to the appraisal of posterior involvement in birdshot retinochoroiditis and Vogt-Koyanagi-Harada disease.
Balci O; Jeannin B; Herbort CP
Int Ophthalmol; 2018 Apr; 38(2):527-539. PubMed ID: 28299496
[TBL] [Abstract][Full Text] [Related]
8. Vogt-Koyanagi-Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area.
Herbort CP; Tugal-Tutkun I; Khairallah M; Abu El Asrar AM; Pavésio CE; Soheilian M
Int Ophthalmol; 2020 Sep; 40(9):2423-2433. PubMed ID: 32418076
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality.
Herbort CP; Abu El Asrar AM; Yamamoto JH; Pavésio CE; Gupta V; Khairallah M; Tugal-Tutkun I; Soheilian M; Takeuchi M; Papadia M
Int Ophthalmol; 2017 Dec; 37(6):1383-1395. PubMed ID: 27844182
[TBL] [Abstract][Full Text] [Related]
10. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
Bacsal K; Wen DS; Chee SP
Am J Ophthalmol; 2008 Mar; 145(3):480-486. PubMed ID: 18191100
[TBL] [Abstract][Full Text] [Related]
11. Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease.
Herbort CP; Abu El Asrar AM; Takeuchi M; Pavésio CE; Couto C; Hedayatfar A; Maruyama K; Rao X; Silpa-Archa S; Somkijrungroj T
Int Ophthalmol; 2019 Jun; 39(6):1419-1425. PubMed ID: 29948499
[TBL] [Abstract][Full Text] [Related]
12. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
13. Vogt-Koyanagi-Harada Disease and Birdshot Retinochoroidopathy, Similarities and Differences: A Glimpse into the Clinicopathology of Stromal Choroiditis, a Perspective and a Review.
Elahi S; Herbort CP
Klin Monbl Augenheilkd; 2019 Apr; 236(4):492-510. PubMed ID: 30891715
[TBL] [Abstract][Full Text] [Related]
14. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease.
Bouchenaki N; Herbort CP
Ophthalmology; 2001 Jan; 108(1):54-64. PubMed ID: 11150265
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of indocyanine green angiography compared to fluorescein angiography and enhanced depth imaging optical coherence tomography during tapering and fine-tuning of therapy in primary stromal choroiditis: A case series.
Elahi S; Gillmann K; Gasc A; Jeannin B; Herbort CP
J Curr Ophthalmol; 2019 Jun; 31(2):180-187. PubMed ID: 31317097
[TBL] [Abstract][Full Text] [Related]
16. Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.
da Silva FT; Hirata CE; Sakata VM; Olivalves E; Preti R; Pimentel SL; Gomes A; Takahashi WY; Costa RA; Yamamoto JH
BMC Ophthalmol; 2012 Aug; 12():40. PubMed ID: 22889440
[TBL] [Abstract][Full Text] [Related]
17. Delayed-onset unilateral Vogt-Koyanagi-Harada syndrome: a multimodal imaging appraisal.
Verma S; Thakur H; Azad SV; Kumar V
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33568408
[TBL] [Abstract][Full Text] [Related]
18. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
Abouammoh MA; Gupta V; Hemachandran S; Herbort CP; Abu El-Asrar AM
Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203
[TBL] [Abstract][Full Text] [Related]
20. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.
Kawaguchi T; Horie S; Bouchenaki N; Ohno-Matsui K; Mochizuki M; Herbort CP
Int Ophthalmol; 2010 Feb; 30(1):41-50. PubMed ID: 19151926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
